NF-kappa-B essential modulator (NEMO) – IkappaB kinase (IKK) complex interface (NEMO–IKK interface)

The NF-kappa-B essential modulator (NEMO) – IkappaB kinase (IKK) complex interface is a pivotal regulatory site within the canonical NF-kappa-B signaling pathway. This interface is formed by the interaction between the N-terminal coiled-coil domain of the regulatory subunit NEMO (also known as IKK-gamma) and a conserved C-terminal hexapeptide sequence, termed the NEMO-binding domain (NBD), found on the catalytic subunits IKK-alpha and IKK-beta. The assembly of this heterotrimeric complex is a prerequisite for the activation of IKK in response to various pro-inflammatory stimuli, such as TNF-alpha and interleukin-1. Once assembled, the complex phosphorylates IkappaB proteins, leading to their degradation and the subsequent nuclear translocation of NF-kappa-B transcription factors. Dysregulation of this interface is linked to chronic inflammatory conditions, autoimmune diseases, and various cancers where constitutive NF-kappa-B activity promotes cell survival and proliferation. Therapeutic strategies targeting this interface, such as cell-permeable NBD peptides and small-molecule mimetics like SR12343, aim to disrupt the protein-protein interaction rather than inhibiting the kinase's catalytic site. This approach is hypothesized to selectively block stimulus-induced NF-kappa-B activation while sparing basal, non-canonical signaling, potentially reducing the toxicity associated with broad IKK inhibitors. However, challenges remain regarding the delivery of peptide-based inhibitors and the potential for systemic immunosuppression or hepatotoxicity.

Other names

NEMO-binding domainNBDIKK-gamma/IKK-alpha/beta interactionIKBKG-IKBKB interactionIKBKG-CHUK interactionIKK complex assembly interface

Disruption of the protein-protein interaction between the N-terminal domain of NEMO and the C-terminal NEMO-binding domain (NBD) of IKK-alpha/beta, preventing IKK complex assembly and subsequent canonical NF-kappa-B activation.